AbstractAdvanced glycation end products (AGEs) that arise from the reaction of sugars with protein side chains are supposed to be involved in the pathogenesis of several diseases and therefore the effects of AGEs on cells are the objective of numerous investigations. Although different cellular responses to AGEs can be measured in cell culture studies, knowledge about the nature of AGE-binding and the involved cell surface receptors is poor. The measurement of AGE-binding to cell surfaces bears the potential to gain a deeper understanding about the nature of AGE-binding to cell surface proteins and could be applied as a preliminary test before performing cell culture studies on AGE effects. Herein, a new material and method for the detectio...
This is the published version. Copyright 1993 American Society for Clinical Investigation.Nonenzymat...
Advanced glycation endproducts (AGE) are a complex and heterogeneous group of compounds formed by th...
Advanced glycation endproducts (AGEs) represent a non-enzymatic posttranslational protein modificati...
Advanced glycation end products (AGEs) are sugar-modified proteins that are known to appear in vivo ...
The advanced glycation end products (AGEs) are organic molecules formed in any living organisms with...
AbstractAdvanced glycation end products (AGEs) that arise from the reaction of sugars with protein s...
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. A...
Advanced glycation endproducts (AGEs) arise in vivo from the reaction of proteins with sugars or dic...
Advanced glycation end products (AGEs) are known to be involved in the pathogenesis of several disea...
Intake of dietary advanced glycation end products (AGEs) is associated with inflammation-related hea...
Reducing sugars and reactive dicarbonyl compounds play a major role in glycation of proteins in vivo...
Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE ...
AbstractThe cellular interaction of proteins modified with advanced glycation end-products (AGEs) is...
Advanced glycation endproducts (AGEs) arise from the reaction of sugars with side chains and the N-t...
Adipose tissue metabolism under hyperglycemia results in Type II diabetes (T2D). To better understan...
This is the published version. Copyright 1993 American Society for Clinical Investigation.Nonenzymat...
Advanced glycation endproducts (AGE) are a complex and heterogeneous group of compounds formed by th...
Advanced glycation endproducts (AGEs) represent a non-enzymatic posttranslational protein modificati...
Advanced glycation end products (AGEs) are sugar-modified proteins that are known to appear in vivo ...
The advanced glycation end products (AGEs) are organic molecules formed in any living organisms with...
AbstractAdvanced glycation end products (AGEs) that arise from the reaction of sugars with protein s...
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. A...
Advanced glycation endproducts (AGEs) arise in vivo from the reaction of proteins with sugars or dic...
Advanced glycation end products (AGEs) are known to be involved in the pathogenesis of several disea...
Intake of dietary advanced glycation end products (AGEs) is associated with inflammation-related hea...
Reducing sugars and reactive dicarbonyl compounds play a major role in glycation of proteins in vivo...
Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE ...
AbstractThe cellular interaction of proteins modified with advanced glycation end-products (AGEs) is...
Advanced glycation endproducts (AGEs) arise from the reaction of sugars with side chains and the N-t...
Adipose tissue metabolism under hyperglycemia results in Type II diabetes (T2D). To better understan...
This is the published version. Copyright 1993 American Society for Clinical Investigation.Nonenzymat...
Advanced glycation endproducts (AGE) are a complex and heterogeneous group of compounds formed by th...
Advanced glycation endproducts (AGEs) represent a non-enzymatic posttranslational protein modificati...